The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
999
April 25, 1997
View Complete Issue         Table of Contents 2019 
Sparfloxacin and Levofloxacin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Sparfloxacin and Levofloxacin
April 25, 1997 (Issue: 999)
Sparfloxacin (Zagam - Rh ne-Poulenc Rorer) and levofloxacin (Levaquin - Ortho-McNeil) are the newest fluoroquinolone antimicrobials to be approved by the US Food and Drug Administration. Sparfloxacin in a once-daily oral preparation is being ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Sparfloxacin and Levofloxacin
Article code: 999a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.